US NIH National Institute on Drug Abuse: Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (Includes AIDS-Related, R01 – Clinical Trial Optional)

Note: This mechanism is for AIDS-related & non AIDS-related research.

Please check Submission Requirements below, as deadlines vary accordingly.

Award Details

A total of five institutes and centres of the National Institutes of Health invite applications for developing the therapeutic potential of the endocannabinoid system for pain treatment (R01 clinical trial optional). This supports projects that seek to elucidate the therapeutic potential of the cannabinoids and endocannabinoid system in the development of mechanism-based therapies for pain. The goal is to understand the role of cannabinoids in the management of chronic pain, in part, to help mitigate the high rate of use and abuse of opioids.

Funding & Duration

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is five years.


US and foreign for-profit and non-profit organisations and public and private organisations are eligible to apply.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.

Comments are closed.